Elanco Animal Health (ELAN) Retained Earnings (2017 - 2026)
Elanco Animal Health (ELAN) posted Retained Earnings of -$2.1 billion for Q1 2026, up 2.61% sequentially from -$2.2 billion in Q4 2025, and down 264.49% YoY from $1.3 billion in Q1 2025.
Elanco Animal Health (ELAN) Retained Earnings (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Retained Earnings for 10 years, with the latest figure at -$2.1 billion in Q1 2026.
- Quarterly Retained Earnings fell 264.49% year-over-year to -$2.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 billion (down 264.49% YoY) and the FY2025 annual result came in at -$2.2 billion, down 124.75% from the prior year.
- Retained Earnings rose to -$2.1 billion in Q1 2026 per ELAN's latest filing, from -$2.2 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $8.9 billion in Q3 2025 and troughed at -$2.2 billion in Q4 2025.
- A 5-year average of $1.3 billion and a median of -$392.0 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 1520.0% in 2022, then surged 2931.29% in 2024.
- Over 5 years, Retained Earnings stood at -$392.0 million in 2022, then soared by 2339.03% to $8.8 billion in 2023, then climbed by 0.46% to $8.8 billion in 2024, then plunged by 124.75% to -$2.2 billion in 2025, then climbed by 2.61% to -$2.1 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$2.1 billion, -$2.2 billion, and $8.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -800.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.88 Bn |
| Mar 31, 2026 | -2.13 Bn |
| Dec 31, 2025 | -2.18 Bn |
| Sep 30, 2025 | 8.85 Bn |
| Jun 30, 2025 | -192.00 Mn |
| Mar 31, 2025 | -583.00 Mn |
| Dec 31, 2024 | 8.82 Bn |
| Sep 30, 2024 | -1.94 Bn |
| Jun 30, 2024 | -542.00 Mn |
| Mar 31, 2024 | 8.78 Bn |
| Dec 31, 2023 | 8.78 Bn |
| Sep 30, 2023 | -2.15 Bn |
| Jun 30, 2023 | -281.00 Mn |
| Mar 31, 2023 | -310.00 Mn |
| Dec 31, 2022 | -392.00 Mn |
| Sep 30, 2022 | -1.01 Bn |
| Jun 30, 2022 | -923.00 Mn |
| Mar 31, 2022 | -186.00 Mn |
| Dec 31, 2021 | -209.00 Mn |
| Sep 30, 2021 | 8.68 Bn |